InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-11.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Tovey Christopher J., Chief Executive Officer. Officer active across 2 companies, notably GW Pharmaceuticals PLC. Cumulatively, 7 disclosures have been published. History available since 5 May 2021. The latest transaction was filed on 5 July 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
4,032 shares@ US$0.020.0% of flowOrdinary SharesSEC:0001765581-22-000069:0
●
1,096 shares@ US$153.220.0011% mcap100.0% of flowOrdinary SharesSEC:0001765581-22-000043:0
7,820 shares0Ordinary SharesSEC:0001765581-22-000032:0
2,496 sharesOrdinary SharesSEC:0000899243-21-018673
2,496 sharesOrdinary SharesSEC:0000899243-21-018673:0
9,091 shares0Ordinary SharesSEC:0001765581-21-000057:0
9,091 shares0Ordinary SharesSEC:0001765581-21-000057
7 of 7 declarations
About Tovey Christopher J.
Christopher J. Tovey is the Chief Operating Officer and Executive Vice President at GW Pharmaceuticals PLC and Jazz Pharmaceuticals plc. In this role, he oversees the daily operations of the company and contributes to the overall strategy. His expertise in the pharmaceutical industry is an asset to both firms.
